Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cancers (Basel) ; 11(4)2019 Apr 04.
Artículo en Inglés | MEDLINE | ID: mdl-30987378

RESUMEN

There has been a renewed interest in the identification of natural products having premium pharmacological properties and minimum off-target effects. In accordance with this approach, natural product research has experienced an exponential growth in the past two decades and has yielded a stream of preclinical and clinical insights which have deeply improved our knowledge related to the multifaceted nature of cancer and strategies to therapeutically target deregulated signaling pathways in different cancers. In this review, we have set the spotlight on the scientifically proven ability of berberine to effectively target a myriad of deregulated pathways.

2.
Pak J Pharm Sci ; 32(6): 2751-2756, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31969311

RESUMEN

Avian influenza or bird flu is a common problem of domestic and wild birds. Some of its strains are able to cross the species barrier and cause infection in various members of class Mammalia. In view of relatively lesser efficacy of vaccines, antiviral therapies remain the only choice for the sustenance of mammals acquiring this highly devastating infection. This study is based on the evaluation of antiviral potential of methanol extracts of eleven selected Cholistani plants. The methanol extracts were prepared by using dried plants material followed by concentrating in a rotary evaporator and finally air dried before dissolving in nanopure water. The suspension was filter sterilized and subjected to in ovo antiviral assays. The allantoic fluids were harvested and haemagglutinin (HA) titers were determined. Among the eleven plants evaluated all methanol extracts were found effective against AIV H9N2 except S. baryosma extract. The medicinal plants O. compressa, N. procumbens, and S. surattense were found to be more effective than others and they retained HA titers at 0 after challenge. The next in order were extracts of O. esculentum, H. salicornicum and S. fruticosa which kept HA titers at 4, 8 and 16 respectively. The extracts of H. recurvum, P. antidotale, S. icolados and A. aspera were found less effective than above mentioned plant extracts and they kept the HA titers at 32, 64, 128 and 256 respectively. These results led us to conclude that the medicinal plants of Cholistan region are a rich source of antiviral agent(s) against AIV H9N2 and could be a source of cost effective alternate therapeutics.


Asunto(s)
Antivirales/farmacología , Extractos Vegetales/farmacología , Plantas Medicinales/química , Animales , Antivirales/aislamiento & purificación , Pollos/virología , Etnobotánica , Pruebas de Hemaglutinación , Gripe Aviar/tratamiento farmacológico , Gripe Aviar/virología , Pakistán , Extractos Vegetales/aislamiento & purificación , Enfermedades de las Aves de Corral/tratamiento farmacológico , Enfermedades de las Aves de Corral/virología
3.
J Cell Biochem ; 119(6): 4293-4303, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29384224

RESUMEN

Curcumin, a bioactive and pharmacologically efficient component isolated from Curcuma longa has attracted considerable attention because of its ability to modulate diverse cellular and physiological pathways. WNT, TGF/SMAD, NOTCH, and SHH are fundamentally different signaling cascades, but their choreographed activation is strongly associated with cancer development and progression. In this review we have attempted to set spotlight on regulation of different cell signaling pathways by curcumin in different cancers. We partition this multi-component review into in-depth biological understanding of various signal transduction cascades and how curcumin targets intracellular signal transducers of deregulated pathways to inhibit cancer development and progression. Rapidly broadening landscape of both established and candidate oncogenic driver mutations identified in different cancers is a major stumbling block in the standardization of drugs having significant clinical outcome. Intra and inter-tumor heterogeneity had leveraged the complexity of therapeutic challenges to another level. Multi-pronged approach and molecularly guided treatments will be helpful in improving the clinical outcome.


Asunto(s)
Antineoplásicos Fitogénicos/uso terapéutico , Curcumina/uso terapéutico , Mutación , Proteínas de Neoplasias , Neoplasias , Transducción de Señal , Investigación Biomédica Traslacional/métodos , Animales , Humanos , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Neoplasias/tratamiento farmacológico , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/patología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Investigación Biomédica Traslacional/tendencias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA